News for Omnicell, Inc. (OMCL)

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Omnicell Inc (OMCL), a leader in transforming pharmacy and nursing care delivery, announced the appointment of Perry A. Genova, PhD, as Senior Vice President an

Omnicell, Inc. (Nasdaq: OMCL) (”œOmnicell” or the ”œCompany”), a leader in transforming the pharmacy and nursing care delivery model, today announced tha

Shares of Omnicell Inc (OMCL) fell 2.69% in mid-day trading on Mar 22. The stock reached an intraday low of $33.62, before recovering slightly to $33.94, do

Shares of Omnicell Inc (OMCL) fell 0.89% in mid-day trading on Mar 21. The stock reached an intraday low of $34.09, before recovering slightly to $34.57, do

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Omnicell, Inc. (NASDAQ:OMCL) (”œOmnicell,” ”œwe,” ”œour,” ”œus,” ”œmanagement,” or the ”œCompany”), a leader in transforming the pharmacy and

OMCL's shares rise on the back of its XT Amplify program gaining market acceptance with its offerings. However, the unfavorable macroeconomic scenario is concerning.

OMCL stays on investors' radar due to its impressive long-term growth initiative.

Omnicell Inc's robust product portfolio and service offerings drive its competitive edge in the healthcare automation market.Transition to SaaS and Expert Serv

Omnicell (OMCL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Omnicell's Q4 2024 earnings showed strong service revenue growth, despite soft overall revenue guidance, highlighting the service business as the key value driver. Read more here.

The average of price targets set by Wall Street analysts indicates a potential upside of 29% in Omnicell (OMCL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

OMCL returns to year-over-year revenue growth in the fourth quarter of 2024.

Total Revenue: $307 million, an increase of $24 million over the prior quarter and $48 million over Q4 2023.Product Revenue: $182 million, up $24 million from

Feb 06, 2025 / 01:30PM GMTOperator Thank you for standing by. My name is Kathleen and I will be your conference operator today. At this time, I would like to we

OMCL stays on investors' radar due to the strong performance of the Advanced Services portfolio.